MMP9 regulates the cellular response to inflammation after skeletal injury

Bone

Volumn 52, Issue 1, 2013, Pages 111-119

  Wang, Xiaodong ^a   Yu, Yan Yiu ^a   Lieu, Shirley ^a   Yang, Frank ^a   Lang, Jeffrey ^a   Lu, Chuanyong ^a   Werb, Zena ^a   Hu, Diane ^a   Miclau, Theodore ^a   Marcucio, Ralph ^a   Colnot, Céline ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IMAGINE INSTITUTE   (France)

Author keywords

Fracture repair; Macrophage; Matrix metalloproteinase; Mechanical environment; Mouse models; Periosteum

Indexed keywords

GELATINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE INJURY; BONE MARROW; BONE REMODELING; CALLUS; CELL DIFFERENTIATION; CELL FATE; CELL INTERACTION; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; ENZYME REGULATION; FRACTURE HEALING; GENE EXPRESSION; HEMATOPOIETIC CELL; INFLAMMATION; MACROPHAGE; MALE; MECHANICAL STIMULATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; PERIOSTEUM GRAFT; STROMA; T LYMPHOCYTE;

ANIMALS; BONE AND BONES; BONE MARROW TRANSPLANTATION; CELL SEPARATION; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT;

EID: 84867138288     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.09.018     Document Type: Article

References (69)

1. Thompson Z., Miclau T., Hu D., et al. A model for intramembranous ossification during fracture healing. J Orthop Res 2002, 20(5):1091-1098.
2. Le A.X., Miclau T., Hu D., et al. Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res 2001, 19(1):78-84.
3. Colnot C., Thompson Z., Miclau T., et al. Altered fracture repair in the absence of MMP9. Development 2003, 130(17):4123-4133.
4. Miclau T., Lu C., Thompson Z., et al. Effects of delayed stabilization on fracture healing. J Orthop Res 2007, 25(12):1552-1558.
5. Pape H.C., Marcucio R., Humphrey C., et al. Trauma-induced inflammation and fracture healing. J Orthop Trauma 2010, 24(9):522-525.
6. Lu C., Miclau T., Hu D., et al. Cellular basis for age-related changes in fracture repair. J Orthop Res 2005, 23(6):1300-1307.
7. Claes L., Recknagel S., Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol 2012, 8(3):133-143.
8. Toben D., Schroeder I., El Khassawna T., et al. Fracture healing is accelerated in the absence of the adaptive immune system. J Bone Miner Res 2011, 26(1):113-124.
9. Xing Z., Lu C., Hu D., et al. Multiple roles for CCR2 during fracture healing. Dis Model Mech 2010, 3(7-8):451-458.
10. Alexander K.A., Chang M.K., Maylin E.R., et al. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res 2011, 26(7):1517-1532.
11. Colburn N.T., Zaal K.J., Wang F., et al. A role for gamma/delta T cells in a mouse model of fracture healing. Arthritis Rheum 2009, 60(6):1694-1703.
12. Gerstenfeld L.C., Cho T.J., Kon T., et al. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 2001, 169(3):285-294.
13. Gerstenfeld L.C., Cho T.J., Kon T., et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 2003, 18(9):1584-1592.
14. Alblowi J., Kayal R.A., Siqueira M., et al. High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol 2009, 175(4):1574-1585.
15. Radi Z.A. Pathophysiology of cyclooxygenase inhibition in animal models. Toxicol Pathol 2009, 37(1):34-46.
16. Abdul-Hadi O., Parvizi J., Austin M.S., et al. Nonsteroidal anti-inflammatory drugs in orthopaedics. J Bone Joint Surg Am 2009, 91(8):2020-2027.
17. Chang J.K., Wu S.C., Wang G.J., et al. Effects of non-steroidal anti-inflammatory drugs on cell proliferation and death in cultured epiphyseal-articular chondrocytes of fetal rats. Toxicology 2006, 228(2-3):111-123.
18. Simon A.M., O'Connor J.P. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am 2007, 89(3):500-511.
19. Xie C., Ming X., Wang Q., et al. COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. Bone 2008, 43(6):1075-1083.
20. Zhang X., Schwarz E.M., Young D.A., et al. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002, 109(11):1405-1415.
21. Wixted J.J., Fanning P.J., Gaur T., et al. Enhanced fracture repair by leukotriene antagonism is characterized by increased chondrocyte proliferation and early bone formation: a novel role of the cysteinyl LT-1 receptor. J Cell Physiol 2009, 221(1):31-39.
22. Granero-Molto F., Weis J.A., Miga M.I., et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 2009, 27(8):1887-1898.
23. Vu T.H., Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000, 14(17):2123-2133.
24. Stickens D., Behonick D.J., Ortega N., et al. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 2004, 131(23):5883-5895.
25. Behonick D.J., Xing Z., Lieu S., et al. Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration. PLoS One 2007, 2(11):e1150.
26. Lieu S., Hansen E., Dedini R., et al. Impaired remodeling phase of fracture repair in the absence of matrix metalloproteinase-2. Dis Model Mech 2011, 4(2):203-211.
27. Dan H., Simsa-Maziel S., Hisdai A., et al. Expression of matrix metalloproteinases during impairment and recovery of the avian growth plate. J Anim Sci 2009, 87(11):3544-3555.
28. Esparza J., Kruse M., Lee J., et al. MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity. FASEB J 2004, 18(14):1682-1691.
29. Corry D.B., Kiss A., Song L.Z., et al. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J 2004, 18(9):995-997.
30. Greenlee K.J., Corry D.B., Engler D.A., et al. Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol 2006, 177(10):7312-7321.
31. Hsu J.Y., McKeon R., Goussev S., et al. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci 2006, 26(39):9841-9850.
32. Gutierrez-Fernandez A., Inada M., Balbin M., et al. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 2007, 21(10):2580-2591.
33. Reif S., Somech R., Brazovski E., et al. Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C. Digestion 2005, 71(2):124-130.
34. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 2009, 24(2):274-282.
35. Colnot C., Huang S., Helms J. Analyzing the cellular contribution of bone marrow to fracture healing using bone marrow transplantation in mice. Biochem Biophys Res Commun 2006, 350(3):557-561.
36. Colnot C.I., Helms J.A. A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev 2001, 100(2):245-250.
37. Ortega N., Wang K., Ferrara N., et al. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis Model Mech 2010, 3(3-4):224-235.
38. Yu Y.Y., Lieu S., Lu C., et al. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Bone 2010, 46(3):841-851.
39. Yu Y.Y., Lieu S., Lu C., et al. Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 2010, 47(1):65-73.
40. Wang Q., Huang C., Zeng F., et al. Activation of the Hh pathway in periosteum-derived mesenchymal stem cells induces bone formation in vivo: implication for postnatal bone repair. Am J Pathol 2010, 177(6):3100-3111.
41. Einhorn T.A., Majeska R.J., Rush E.B., et al. The expression of cytokine activity by fracture callus. J Bone Miner Res 1995, 10(8):1272-1281.
42. Cho T.J., Gerstenfeld L.C., Einhorn T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 2002, 17(3):513-520.
43. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998, 46(Suppl. 355):S7-S21.
44. Rundle C.H., Wang H., Yu H., et al. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone 2006, 38(4):521-529.
45. Heiner D.E., Meyer M.H., Frick S.L., et al. Gene expression during fracture healing in rats comparing intramedullary fixation to plate fixation by DNA microarray. J Orthop Trauma 2006, 20(1):27-38.
46. Claes L., Ignatius A., Lechner R., et al. The effect of both a thoracic trauma and a soft-tissue trauma on fracture healing in a rat model. Acta Orthop 2011, 82(2):223-227.
47. Recknagel S., Bindl R., Kurz J., et al. Experimental blunt chest trauma impairs fracture healing in rats. J Orthop Res 2011, 29(5):734-739.
48. Ulivi V., Lenti M., Gentili C., et al. Anti-inflammatory activity of monogalactosyldiacylglycerol in human articular cartilage in vitro: activation of an anti-inflammatory cyclooxygenase-2 (COX-2) pathway. Arthritis Res Ther 2011, 13(3):R92.
49. Lu C., Saless N., Hu D., et al. Mechanical stability affects angiogenesis during early fracture healing. J Orthop Trauma 2011, 25(8):494-499.
50. Vu T.H., Shipley J.M., Bergers G., et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93(3):411-422.
51. Giordano A., Galderisi U., Marino I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007, 211(1):27-35.
52. Satija N.K., Singh V.K., Verma Y.K., et al. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med 2009, 13(11-12):4385-4402.
53. Xing Z., Lu C., Hu D., et al. Rejuvenation of the inflammatory system stimulates fracture repair in aged mice. J Orthop Res 2010, 28(8):1000-1006.
54. Simmons P.J., Przepiorka D., Thomas E.D., et al. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 1987, 328(6129):429-432.
55. Rieger K., Marinets O., Fietz T., et al. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Exp Hematol 2005, 33(5):605-611.
56. Wang Q., Huang C., Xue M., et al. Expression of endogenous BMP-2 in periosteal progenitor cells is essential for bone healing. Bone 2011, 48(3):524-532.
57. Colnot C., Zhang X., Tate M.L. Current insights on the regenerative potential of the periosteum: Molecular, cellular, and endogenous engineering approaches. J Orthop Res 2012, [Epub ahead of print]. 10.1002/jor.22181.
58. Huang Y., Zhang X., Du K., et al. Inhibition of beta-catenin signaling in chondrocytes induces delayed fracture healing in mice. J Orthop Res 2012, 30(2):304-310.
59. Hankemeier S., Grassel S., Plenz G., et al. Alteration of fracture stability influences chondrogenesis, osteogenesis and immigration of macrophages. J Orthop Res 2001, 19(4):531-538.
60. Kan L., Liu Y., McGuire T.L., et al. Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification. Stem Cells 2009, 27(1):150-156.
61. Tsuji K., Bandyopadhyay A., Harfe B.D., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006, 38(12):1424-1429.
62. Karamichos D., Skinner J., Brown R., et al. Matrix stiffness and serum concentration effects matrix remodelling and ECM regulatory genes of human bone marrow stem cells. J Tissue Eng Regen Med 2008, 2(2-3):97-105.
63. McBride S.H., Dolejs S., Brianza S., et al. Net change in periosteal strain during stance shift loading after surgery correlates to rapid de novo bone generation in critically sized defects. Ann Biomed Eng 2011, 39(5):1570-1581.
64. Mountziaris P.M., Spicer P.P., Kasper F.K., et al. Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng B Rev 2011, 17(6):393-402.
65. Huang C., Ogawa R. Mechanotransduction in bone repair and regeneration. FASEB J 2010, 24(10):3625-3632.
66. Palomares K.T., Gleason R.E., Mason Z.D., et al. Mechanical stimulation alters tissue differentiation and molecular expression during bone healing. J Orthop Res 2009, 27(9):1123-1132.
67. Rosen V. Harnessing the parathyroid hormone, Wnt, and bone morphogenetic protein signaling cascades for successful bone tissue engineering. Tissue Eng B Rev 2011, 17(6):475-479.
68. Sibai T., Morgan E.F., Einhorn T.A. Anabolic agents and bone quality. Clin Orthop Relat Res 2011, 469(8):2215-2224.
69. Chen Y., Whetstone H.C., Lin A.C., et al. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med 2007, 4(7):e249.